SQ sublingual immunotherapy tablets for children with allergic rhinitis: A review of phase three trials.

Peter CsonkaEckard HamelmannMirjana TurkaljGraham RobertsDouglas P Mack

Published in: Acta paediatrica (Oslo, Norway : 1992) (2024)

Evidence supports use of SQ SLIT tablets in children and adolescents with allergic rhinitis or rhinoconjunctivitis, with and without asthma. Long-term data demonstrate disease-modifying effects of SQ grass SLIT tablet and suggest the clinical relevance of initiating allergy immunotherapy earlier in the disease course.

Keyphrases

allergic rhinitis
young adults
electronic health record
big data
atopic dermatitis
machine learning
cystic fibrosis
data analysis
air pollution
artificial intelligence